HomeHealthcare & Life SciencesPharmaceuticals Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market

Russia Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Size & Outlook, 2026-2034


Russia Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market Insights

  • Based on Reed Intelligence findings, the Russia Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market reached USD 3.39 Million in 2025 and is estimated to attain USD 7.51 Million by 2034.
  • From 2026 to 2034, the Russia market is expected to grow at a steady CAGR of 9.22%.
  • Within the Treatment Type category, Drug Therapy dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Gene Therapy is forecasted to deliver the fastest growth, positioning it as the most lucrative Treatment Type segment.

Other Key Findings


  • In 2025, Russia represented 1.83% of the overall global Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size.
  • United States is projected to lead the global Gamma Aminobutyric Acid Transaminase Deficiency Treatment Market size by 2034.
  • Across Europe, Germany is anticipated to hold the dominant position in market size by 2034.
  • Spain is forecasted to expand at the fastest pace in Europe, attaining USD 7.79 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 3.39 Million
Market Size In 2034 USD 7.51 Million
Largest segment Drug Therapy
Units Revenue in USD Million
CAGR 9.22% (2026-2034)
Segmnetation Covered
Treatment Type
  1. Drug Therapy
  2. Gene Therapy
  3. Supportive Therapy
Route of Administration
  1. Oral
  2. Injectable
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Homecare Settings
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports